Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

187results about How to "Increase cerebral blood flow" patented technology

Stimulation for treating brain events and other conditions

Apparatus for treatment is provided, including one or more electrodes, configured to be applied to a site of a subject, and adverse cerebrovascular condition treatment functionality. The functionality comprises a control unit configured to drive the one or more electrodes to apply electrical stimulation to the site during a plurality of stimulation periods which includes at least first and last stimulation periods, set an inter-period interval between initiation of the first stimulation period and initiation of the last stimulation period to be at least 24 hours, and configure the stimulation during the first and last stimulation periods to induce at least one neuroprotective occurrence selected from the group consisting of: an increase in cerebral blood flow (CBF) of the subject, and a release of one or more neuroprotective substances. The site is selected from the group consisting of: a sphenopalatine ganglion (SPG), a greater palatine nerve, a lesser palatine nerve, a sphenopalatine nerve, a communicating branch between a maxillary nerve and an SPG, an otic ganglion, an afferent fiber going into the otic ganglion, an efferent fiber going out of the otic ganglion, an infraorbital nerve, a vidian nerve, a greater superficial petrosal nerve, and a lesser deep petrosal nerve. Additional embodiments are also described.
Owner:BRAINSGATE LTD

Stimulation for treating brain events and other conditions

ActiveUS8055347B2Increase cerebral blood flowHarmful conditionSpinal electrodesArtificial respirationDiseaseDeep petrosal nerve
Apparatus for treatment is provided, including one or more electrodes, configured to be applied to a site of a subject, and adverse cerebrovascular condition treatment functionality. The functionality comprises a control unit configured to drive the one or more electrodes to apply electrical stimulation to the site during a plurality of stimulation periods which includes at least first and last stimulation periods, set an inter-period interval between initiation of the first stimulation period and initiation of the last stimulation period to be at least 24 hours, and configure the stimulation during the first and last stimulation periods to induce at least one neuroprotective occurrence selected from the group consisting of: an increase in cerebral blood flow (CBF) of the subject, and a release of one or more neuroprotective substances. The site is selected from the group consisting of: a sphenopalatine ganglion (SPG), a greater palatine nerve, a lesser palatine nerve, a sphenopalatine nerve, a communicating branch between a maxillary nerve and an SPG, an otic ganglion, an afferent fiber going into the otic ganglion, an efferent fiber going out of the otic ganglion, an infraorbital nerve, a vidian nerve, a greater superficial petrosal nerve, and a lesser deep petrosal nerve. Additional embodiments are also described.
Owner:BRAINSGATE LTD

Medicament for treating senile dementia and preparation method thereof

The present invention relates to a medicine for curing senile dementia. The medicine is composed of capsule and oral liquid; wherein, the capsule contains 16 to 20 portions of red ginseng, 16 to 20 portions of leech and 16 to 20 portions of ground beetles; the oral liquid contains 52 to 60 portions of prepared tuber of multiflower knotweed, 24 to 30 portions of Chinese dodder seed, 16 to 20 portions of cynomorium songaricum, 24 to 30 portions of epimedium herb, 16 to 20 portions of rehmannia root, 16 to 20 portions of common anemarrhena rhizome, 24 to 30 portions of medlar, 26 to 32 portions of radix astragali, 16 to 20 portions of hemlock parsley, 24 to 30 portions of salvia miltiorrhiza, 16 to 20 portions of radix puerariae, 8 to 10 portions of bile arisaema, 8 to 10 portions of grassleaf sweelflag rhizome, 8 to 10 portions of liquorice, 18 to 22 portions of gastrodia tuber and 0.5 to 1 portions of benzoate. The medicine has the efficacies of nourishing bone marrow, strengthening brain, enriching qi and invigorating blood, and removing blood stasis. After using the medicine, the content of serum cholesterin and triglyceride obviously decreases, the content of high density lipoprotein and superoxide dismutases increases, the content of plasm LPO decreases and the effect of blood fat reducing and free radical clearing is obvious. In addition, the medicine has the remarkable efficacies of expanding brain blood vessel and increasing brain blood flow volume.
Owner:孙彩虹

Anti-fatigue medicinal liquor capable of tonifying kidney yang

The invention relates to anti-fatigue medicinal liquor capable of tonifying kidney yang, prepared from the following raw materials: buckwheat wine and the following Chinese herbal medicines: sealwort, American ginseng, Chinese date, peach kernel, cordyceps militaris, male silkworm chrysalis, bee milk and honey. According to the anti-fatigue medicinal liquor capable of tonifying kidney yang disclosed by the invention, the buckwheat wine can be fully used for invigorating blood circulation, carrying medicine and increase energy, the American ginseng is used for tonifying primordial qi and eliminating physical fatigue, the sealwort can tonify the liver and kidney and can support the healthy energy and encourage yang, the Chinese date can nourish blood and calm the nerves and can relieve fatigue, the peach kernel can invigorate blood circulation to remove blood stasis, can improve blood supply of the brain and can repair nerve injury, and the cordyceps militaris, male silkworm chrysalis and bee milk can invigorate kidney qi, add energy and encourage yang. The medicines are mutually matched, fatigue can be well eliminated, the kidney can be tonified, and yang can be encouraged, thus the medicinal liquor disclosed by the invention is applicable to men and women.
Owner:宁强县老羌寨生态农业发展有限责任公司

Lung moistening and detoxifying soybean milk and preparation method thereof

The invention discloses lung moistening and detoxifying soybean milk which is prepared from the following raw materials in weight part: 70-80 parts of soybeans, 40-50 parts of snap beans, 30-40 parts of buckwheat, 15-20 parts of lotus root starch, 2-3 parts of rhodiola, 1-2 parts of bulbus fritillariae cirrhosae, 1-2 parts of apocynum venetum, 1-3 parts of cherokee rose fruit, 20-30 parts of pawpaw, 20-30 parts of kiwi fruit, 20-25 parts of lentinus edodes, 20-25 parts of torreya grandis, 5-6 parts of mint, 6-7 parts of white sugar, 1-2 parts of a food additive and a proper amount of water. The soybean milk disclosed by the invention is improved based on the traditional soybean milk and added with natural food materials and medicinal materials with the excellent health care function; the snap beans have the effects of moistening lung, diminishing inflammation, maintaining beauty, reinforcing bone, invigorating stomach, relieving internal heat or fever and the like; the torreya grandis has the effects of killing worms, dispersing accumulation, relieving a cough, moistening lung for removing phlegm, lubricating intestines, removing haemorrhoids, tonifying spleen, tonifying qi, removing stasis to produce new and the like, and the effects of moisturizing skin, delaying senescence and protecting eyesight can be realized when the soybean milk is oftendrunk; the rhodiola has the effects of promoting blood circulation, stopping bleeding, resolving toxin, dispersing swelling, resisting and preventing aging, improving cerebral blood flow, improving immunity of the organism, resisting radiation, resisting fatigue, increasing appetite, and promoting sleep, and has a dual-direction regulation effect on an endocrine system.
Owner:ANHUI JINCAIDI FOOD

Preparation method of injection for treating cardio-cerebral vascular diseases

The invention discloses a preparation method of an injection for treating cardio-cerebral vascular diseases. The preparation method is characterized by comprising the following steps of: a, adding ethanol into a medical medicinal material such as panax notoginseng, heating for refluxing to prepare a panaxtriol extracting solution; b, primarily clarifying the panaxtriol extracting solution prepared in a; c, concentrating the panaxtriol extracting solution subjected to the primary clarification in b and separating through using macroporous resins, wherein the separation process is used for primary purification; and d, ultrafiltering the panaxtriol extracting solution subjected to the primary purification in c to prepare panax notoginseng saponins; and then processing the panax notoginseng saponins to prepare a finished product. The prepared injection for treating the cardio-cerebral vascular diseases has light colour, low content of impurities, high content of active ingredients, high bioavailability and good safety, is beneficial to absorption by a human body as well as can satisfy first-aid requirements of patients suffered from various cardio-cerebral vascular diseases such as cerebral thrombosis, cerebral infarction, stenocardia, myocardial infarction and the like; furthermore, the injection can be used as an excellent agent for inhabiting blood platelet congregating and has the efficacies of reducing blood viscosity and increasing cerebral blood flow.
Owner:TIANSHENG PHARMA GROUP
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products